Skip to main content
Clinical Trials/NCT03278639
NCT03278639WithdrawnNot Applicable

Randomized, Blind, Controlled Clinical Trial to Assess the Efficacy and Safety or Rhythmic Auditory Stimulation (RAS) for Gait and Balance Disorders in Parkinson's Disease

Pontifical Catholic University of Argentina0 sitesStarted: March 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Sponsor
Primary Endpoint
change from baseline in Tinetti scale total score

Study Overview

Brief Summary

Gait deficits are among the most characteristic and most functionally debilitating signs of the motor neuropathology of Parkinson's disease (PD). Rhythmic Auditory Stimulation (RAS) is a technique by which a series of auditory stimuli are presented at a fixed rhythm, so that patients have to synchronize their movements to the rhythms. In this study, auditory stimuli will be constituted by Tango musical pieces, which tempo is modified to adapt to patients' walking cadence. Previous results suggested that RAS can increase Tinetti's gait and balance and may also improve Health-Related Quality of Life. This will be a randomized, blind, controlled clinical trial to further assess RAS efficacy and safety.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Masking Description

Both investigators taking care of patients and outcomes assessors will be blinded.

Eligibility Criteria

Ages
60 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Clinically definitive or probable PD diagnosis
  • Gait disorders (MDS-UPDRS #2.12 =1)
  • Patients that can be reasonably expected to remain in ON-state during training sessions.

Exclusion Criteria

  • Previous use of RAS or kinesiology
  • MMSE >= 24
  • BDI >= 17
  • Patients having undergone PD surgical treatments.
  • Patients with auditory or visual handicaps

Outcomes

Primary Outcomes

change from baseline in Tinetti scale total score

Time Frame: 4 weeks

Secondary Outcomes

  • change from baseline in PDQ-39 scores(4 weeks)
  • change from baseline in Beck Depression Index (BDI)(4 weeks)
  • change from baseline in Tinetti scale total score(6 months)
  • change from baseline in MMSE (Mini-Mental State Examination)(4 weeks)
  • change from baseline in Fall diary(4 weeks)
  • change from baseline in Tinetti scale Gait score(4 weeks)
  • change from baseline in Tinetti scale Balance score(4 weeks)
  • change from baseline in Timed Up & Go test (TUG)(4 weeks)
  • change from baseline in MDS-UPDRS score(4 weeks)

Investigators

Sponsor
Pontifical Catholic University of Argentina
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Santiago Perez Lloret

MD PhD CPI

Pontifical Catholic University of Argentina

Similar Trials